Projects funded by the NCN
Novel inhibitors of herpes virus protease
2017/27/N/NZ6/02328
Keywords:
herpes inhibitor VP24 protease
Descriptors:
- NZ6_5: Virology
- NZ1_1: Molecular biology
- NZ1_2: Biochemistry
Panel:
NZ6 - Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution :
Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 14 - announced on 2017-09-15
Amount awarded: 139 400 PLN
Project start date (Y-m-d): 2018-07-26
Project end date (Y-m-d): 2021-07-25
Project duration:: 36 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Equipment purchased [PL]
- Komputer osobisty (4 937 PLN)
Information in the final report
- Publication in academic press/journals (1)
- Novel inhibitors of HSV-1 protease effective in vitro and in vivoAuthors:Magdalena Pachota, Renata Grzywa, Jakub Iwanejko, Aleksandra Synowiec, Dominika Iwan, Karolina Kamińska, Marcin Skoreński, Ewa Bielecka, Krzysztof Szczubiałka, Maria Nowakowska, Cameron D. Mackereth, Elżbieta Wojaczyńska, Marcin Sieńczyk, Krzysztof PyrćAcademic press:Antivral Research (rok: 2022, tom: 213, strony: 105604), Wydawca: ElsevierStatus:PublishedDOI:10.1016/j.antiviral.2023.105604 - link to the publication